Quick Summary
Tuccatinn 150mg Tablet
Last updated on 26 Sep 2026 | 08:41 AM (IST)
₹35035
MRP: ₹42195.94
(You Save ₹7160.94)
60 TABLET(s) IN A BOTTLE
Tuccatinn 150mg Tablet
Salt Composition
TUCATINIBMarketer
BDR PHARMACEUTICALS INTERNATIONALS PVT LTD
17% OFF
₹35035
MRP: ₹42,195.94
Inclusive of all taxes
17% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Tucaliv 150mg Tablet
HETERO HEALTHCA...
₹ 416.63/tablet
28% cheaper
Tucanat 150mg Tablet
NATCO PHARMA LT...
₹ 497.13/tablet
14% cheaper
Tukavo 150mg Tablet
ZYDUS CADILA
₹ 505.00/tablet
13% cheaper
Tucator 150mg Tablet
TORRENT PHARMAC...
₹ 620.40/tablet
7% costlier
Better Service Satisfied Customers
Introduction
Tuccatinn 150mg Tablet is a medicine used to treat a specific type of breast cancer called HER2-positive breast cancer, especially when it has spread to other parts of the body, including the brain. It is usually given along with two other medicines—trastuzumab and capecitabine.
This medicine works by blocking a protein (HER2) that helps cancer cells grow. By doing this, Tuccatinn 150mg Tablet helps slow down or stop the cancer from spreading further.
It is not a chemotherapy drug. It is a targeted therapy, which means it attacks cancer cells more specifically and causes less harm to healthy cells. It is given only with a doctor’s advice and regular checkups are needed during treatment to make sure the medicine is working safely.
Uses
Tuccatinn 150mg Tablet is used for:
-
HER2-positive advanced or metastatic breast cancer
-
Brain metastases in HER2+ breast cancer patients
-
Use in combination with trastuzumab and capecitabine after previous HER2-directed therapies
This therapy is typically considered when other standard HER2 treatments have become ineffective.
How it Works
Tuccatinn 150mg Tablet belongs to a group of medicines known as tyrosine kinase inhibitors (TKIs). It works by:
-
Specifically targeting the HER2 receptor, a protein that promotes cancer cell growth
-
Blocking HER2-related signaling pathways that drive tumor progression
-
Working synergistically with other anticancer drugs like trastuzumab and capecitabine
-
Crossing the blood-brain barrier to treat cancer that has spread to the brain
This focused mechanism helps slow disease progression while minimizing impact on normal cells.
Interaction of Tuccatinn 150mg Tablet with Other Drugs
Inform your doctor about all medicines, supplements, or herbal products you are taking. Tuccatinn 150mg Tablet may interact with:
-
Azole antifungals (e.g., ketoconazole, itraconazole)
-
Macrolide antibiotics (e.g., clarithromycin)
-
Rifampin and rifabutin (may reduce itslevels)
-
Anticonvulsants like phenytoin, carbamazepine
-
St. John’s Wort (a herbal product that can reduce effectiveness)
-
Proton pump inhibitors and other acid-lowering agents
These interactions may either increase toxicity or reduce the effectiveness of Tablet.
Storage Information
-
Store below 30°C in a dry place, away from direct sunlight.
-
Keep in the original blister or bottle until ready to use.
-
Do not freeze or expose to moisture.
-
Keep out of reach of children and pets.
-
Safely discard expired or unused capsules—do not flush them.
How to Take it
-
Take it by mouth, exactly as prescribed by your oncologist.
-
Usually taken twice a day (every 12 hours), with or without food.
-
Swallow capsules whole with water. Do not crush, chew, or open them.
-
Take at the same time every day to maintain steady drug levels.
-
If vomiting occurs after taking a dose, do not retake it. Wait for the next scheduled dose.
-
Do not miss doses, and do not stop without consulting your doctor.
Safety Advices
Pregnancy
Use of this medicine is not recommended during pregnancy. Women of childbearing potential should use effective contraception during treatment and for at least 1 week after the last dose to avoid potential harm to the unborn baby.
Breast Feeding
Breastfeeding is not advised while taking this medicine, as it may pass into breast milk and could harm the baby. Talk to your doctor about safer alternatives or when it's safe to resume breastfeeding.
Liver
Regular liver tests are advised, as Tuccatinn 150mg Tablet can cause liver enzyme elevation.
Driving
Use caution some patients report dizziness or fatigue.
Lungs
Tuccatinn 150mg Tablet should be used with caution in lung cancer patients, and only under the supervision of an oncologist, as it may cause serious side effects like liver toxicity and diarrhea.
Alcohol
Should be avoided or minimized, as it may worsen liver-related side effects.
Side Effects
Common Side Effects
Some people may have:
-
Loose motion (diarrhea)
-
Feeling very tired
-
Nausea or vomiting
-
Mouth sores
-
Less hunger
-
Red or sore hands and feet
-
Liver test changes (seen in blood reports)
These usually go away with time or treatment. Tell your doctor if any feel too strong or last long.
Serious Side Effects (Call Your Doctor Right Away)
-
Yellow skin or eyes (could mean a liver problem)
-
Bad diarrhea with weakness
-
Trouble breathing or swelling (could be an allergy)
-
High fever or infections
Report any unexpected or persistent side effects to your doctor immediately.
Quick Tips
-
Keep oral rehydration salts (ORS) handy in case of diarrhea.
-
Use sunscreen and moisturizers to prevent skin reactions on hands and feet.
-
Stick to a mild diet if experiencing nausea; avoid spicy or greasy foods.
-
Inform your healthcare provider if you’re taking any over-the-counter meds.
-
Track side effects daily using a treatment journal—it helps your doctor manage symptoms early.
FAQs
Q1.
What is Tuccatinn 150mg Tablet used for?
Tuccatinn 150mg Tablet is used to treat HER2-positive breast cancer that has spread to other parts of the body, including the brain. It is usually given along with trastuzumab and capecitabine, especially when earlier treatments have stopped working.
Q2.
What makes Tuccatinn 150mg Tablet different from chemotherapy?
It is a targeted therapy. Unlike chemotherapy, it blocks a specific protein called HER2 found on cancer cells, helping slow or stop their growth while doing less harm to healthy cells.
Q3.
What is the usual dose for patients?
Doctors generally prescribe 300 mg twice a day, which means two 150 mg tablets in the morning and two in the evening. It can be taken with or without food
Q4.
What to do if a dose is missed or vomited?
If it’s been more than 8 hours since the missed dose, skip it and wait for your next regular dose. Never take two doses at once. If vomiting happens after taking it, do not retake—just continue with the next scheduled dose.
Q5.
Can Tuccatinn 150mg Tablet help when cancer spreads to the brain?
Yes. Tuccatinn 150mg Tablet is known to work even when breast cancer has spread to the brain, making it one of the few oral cancer medicines that reach the brain and provide benefit.
Fact Box
| Molecule Name: Tucatinib | Therapeutic Class: Anticancer (HER2-directed therapy) |
| Pharmacological Class: Tyrosine kinase inhibitor |
Indications: HER2-positive metastatic breast cancer (incl. brain mets) |
References
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
P. Thirumal Reddy
B. Pharm

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 26 Sep 2026 | 08:41 AM (IST)

Want to know more?
Read Our Editorial Policy







